PAPI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.608
EU - Europa 6.255
AS - Asia 3.639
SA - Sud America 496
AF - Africa 103
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.538
PL - Polonia 2.005
RU - Federazione Russa 1.752
SG - Singapore 1.011
CN - Cina 833
IT - Italia 760
HK - Hong Kong 556
VN - Vietnam 469
IE - Irlanda 400
BR - Brasile 392
SE - Svezia 337
KR - Corea 301
DE - Germania 240
FI - Finlandia 170
FR - Francia 159
UA - Ucraina 155
IN - India 136
GB - Regno Unito 110
AU - Australia 58
JO - Giordania 44
JP - Giappone 44
CA - Canada 42
ID - Indonesia 42
TR - Turchia 42
AR - Argentina 41
NL - Olanda 40
BD - Bangladesh 35
ES - Italia 25
IQ - Iraq 22
CH - Svizzera 20
CI - Costa d'Avorio 19
EC - Ecuador 18
ZA - Sudafrica 18
BE - Belgio 17
AT - Austria 16
MX - Messico 16
PK - Pakistan 12
SA - Arabia Saudita 12
EG - Egitto 11
NG - Nigeria 11
AE - Emirati Arabi Uniti 10
MA - Marocco 10
UZ - Uzbekistan 10
CL - Cile 9
CO - Colombia 9
CZ - Repubblica Ceca 9
IR - Iran 9
PY - Paraguay 9
PH - Filippine 8
KE - Kenya 7
VE - Venezuela 7
AZ - Azerbaigian 6
HR - Croazia 5
LV - Lettonia 5
NP - Nepal 5
PE - Perù 5
UY - Uruguay 5
AL - Albania 4
BJ - Benin 4
LU - Lussemburgo 4
MY - Malesia 4
OM - Oman 4
RO - Romania 4
SC - Seychelles 4
TH - Thailandia 4
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
LY - Libia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
CY - Cipro 2
GT - Guatemala 2
LB - Libano 2
ML - Mali 2
MN - Mongolia 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
LK - Sri Lanka 1
Totale 19.156
Salva come PNG Salva come JPEG
Città #
Warsaw 2.003
Santa Clara 1.632
Ashburn 1.017
Fairfield 833
Singapore 724
Hong Kong 463
Chandler 452
Dublin 400
Woodbridge 381
Seattle 369
Houston 323
Cambridge 321
Seoul 293
Wilmington 279
San Jose 226
Jacksonville 224
Beijing 167
Hefei 153
Ho Chi Minh City 151
Ann Arbor 140
Lawrence 136
Florence 133
Altamura 132
Princeton 119
The Dalles 119
Lauterbourg 105
Buffalo 104
Hanoi 102
Los Angeles 89
Munich 88
Mumbai 79
Moscow 73
Medford 67
Boardman 60
Boston 56
Melbourne 54
New York 54
Dallas 53
Council Bluffs 52
Shanghai 45
Helsinki 44
Milan 44
Tokyo 41
Kent 40
São Paulo 38
San Diego 36
Jakarta 32
Turku 29
Dong Ket 28
Clifton 26
Rome 26
Dearborn 25
Falls Church 24
Paris 23
Redondo Beach 23
Frankfurt am Main 22
Haiphong 21
Abidjan 18
Norwalk 18
Chicago 17
Guangzhou 17
Bern 16
Da Nang 16
London 16
Orem 16
Phoenix 15
Brussels 14
Izmir 14
Lappeenranta 14
Barcelona 13
Toronto 13
Hải Dương 12
Tianjin 12
Chennai 11
Denver 11
Abuja 10
Ankara 10
Montreal 10
Andover 9
Campinas 9
Johannesburg 9
Tashkent 9
Yubileyny 9
Atlanta 8
Belo Horizonte 8
Brooklyn 8
Curitiba 8
Manchester 8
Redmond 8
Redwood City 8
Shenzhen 8
Wuhan 8
Baghdad 7
Bengaluru 7
Biên Hòa 7
Bremen 7
Cascina 7
Dhaka 7
Lucca 7
Naples 7
Totale 13.259
Salva come PNG Salva come JPEG
Nome #
NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis 353
A systematic assessment of accuracy in detecting somatic mosaic variants by deep amplicon sequencing: Application to NF2 gene 318
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 316
Raccomandazioni cliniche per il carcinoma mammario 315
Characterization of an Italian founder mutation in the RING-finger domain of BRCA1 281
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor 280
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers 258
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. 254
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases 248
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification 248
Fatal Malonyl CoA Decarboxylase Deficiency Due to Maternal Uniparental Isodisomy of the Telomeric End of Chromosome 16 247
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 236
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus 232
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 229
MUTYH c.933+3A>C, associated with a severely impaired gene expression, is the first Italian founder mutation in MUTYH-Associated Polyposis. 227
Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. 227
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers 226
A PALB2 germline mutation associated with hereditary breast cancer in Italy. 225
Evaluation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Mutation Detection 224
[Y chromosome abnormalities and azoospermia. Description of 2 cases] 216
Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. 215
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia 213
Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants 211
Broadening the spectrum of SMARCB1-associated malignant tumors: A case of uterine leiomyosarcoma in a patient with schwannomatosis 210
A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. 208
PREMATURE OVARIAN FAILURE AND FRAGILE X PREMUTATION: A STUDY ON 45 WOMEN 206
A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency 202
Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. 201
Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism. 200
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. 199
Breast cancer: the first comparative evaluation of oncobiome composition between males and females 198
Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. 196
Genetic insights into familial tumors of the nervous system. 196
A novel microdeletion syndrome with loss of the MSH2 locus and hereditary non-polyposis colorectal cancer. 195
Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin. 192
Application of COLD-PCR for improved detection of NF2 mosaic mutations 192
Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy. 188
The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome 187
Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. 186
Expanding the mutational spectrum of LZTR1 in schwannomatosis. 184
Update of NGS analysis of Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 183
Correlation between cytogenetic data and ganglioside pattern in human meningiomas. 182
Cytogenetic studies in sporadic and multiple endocrine neoplasia type 1-associated pituitary adenomas. 182
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 181
Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 181
A kindred with MYH-associated polyposis and pilomatricomas. 180
Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma 179
Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation 176
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. 175
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. 172
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 171
Detection of rearrangements in the NF2 gene using semi-quantitative multiplex fluorescent PCR. 169
Germline mutations in MSH2 and ATM gene in patients with GIST (gastrointestinal stromal tumor) and second epitelial tumors 168
NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis. 167
Detection of BRCA1 and BRCA2 variants in circulating free DNA by using a commercial kit 165
Epigenomic, genomic, and transcriptomic landscape of schwannomatosis 164
Multiple spinal ganglioneuromas in a patient harboring a pathogenic NF1 mutation. 163
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 161
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) 161
Evidence for a human mitotic mutant with pleiotropic effect. 158
An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene. 156
Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. 153
Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene. 152
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 152
Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico-pathological variables. 151
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation 149
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 149
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. 146
Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. 146
Schwannomatosis associated schwannomas show a different NF2 mutational spectrum compared to Neurofibromatosis type 2 patients 145
Thymidylate synthase and orotate phosphoribosyl-transferase gene expression and genotype as predictors for clinical outcome in colorectal cancer patients treated with 5-fluorouracil 142
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 142
Beta endorphin in obese and anorexia nervosa patients 140
Expression of epidermal growth factor, transforming growth factor-alpha and their receptor in the human oesophagus. 139
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases 138
Alu–Mediated Duplication and Deletion of Exon 11 Are Frequent Mechanisms of PALB2 Inactivation, Predisposing Individuals to Hereditary Breast–Ovarian Cancer Syndrome 137
Genome-wide Association Study Identifies 32 Novel Breast Cancer Susceptibility Loci From Overall and Subtype-Specific Analyses 137
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 135
Typical NF2 and LTZR1 mutations are retained in an immortalized human schwann cell model of schwannomatosis 134
PALB2 mutations in male breast cancer: a population-based study in Central Italy. 134
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 133
Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes 130
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. 129
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers 129
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. 128
The neurofibromatosis type 2 gene is inactivated in schwannomas. 127
Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations 127
True hermaphroditism: a new case with complex mosaicism. 125
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events. 125
Types, stability, and phenotypic consequences of chromosome rearrangements leading to interstitial telomeric sequences. 124
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. 124
Influence of TYMS expression and genotype on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 122
Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers. 121
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 121
Dinucleotide repeat polymorphism at the RBP3 locus in chromosome band 10q11.2. 121
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 119
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. 117
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis 115
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. 115
Duplicated KOX zinc finger gene clusters flank the centromere of human chromosome 10: evidence for a pericentric inversion during primate evolution. 114
Totale 17.920
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 0 0 0 0 0 64 94
2021/2022753 33 71 81 20 29 26 38 60 34 31 128 202
2022/20231.928 188 397 80 116 152 327 230 116 199 21 58 44
2023/2024806 21 73 111 46 43 89 37 227 21 43 60 35
2024/20254.835 148 505 323 771 1.409 646 61 237 220 140 194 181
2025/20265.070 603 799 432 502 696 271 717 271 325 339 115 0
Totale 19.362